MedPath

Nortrel 7/7/7

(norethindrone and ethinyl estradiol tablets USP, 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg)

Approved
Approval ID

992dcc56-90ab-4691-8114-16d47a8b9982

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 31, 2021

Manufacturers
FDA

Teva Pharmaceuticals USA, Inc.

DUNS: 001627975

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0555-9012
Application NumberANDA075478
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone and Ethinyl Estradiol
Product Specifications
Effective DateDecember 31, 2021
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.